These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33930221)

  • 41. Association between Circulating B-Type Natriuretic Peptide and Diabetic Peripheral Neuropathy: A Cross-Sectional Study of a Chinese Type 2 Diabetic Population.
    Yan P; Wan Q; Zhang Z; Xu Y; Miao Y; Chen P; Gao C
    J Diabetes Res; 2020; 2020():3436549. PubMed ID: 33110921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Blood miR-216a, miR-377 and Their Target Genes ANGPTL4, GAP-43 and Serum of PPARG as Biomarkers for Diabetic Peripheral Neuropathy of Type 2 Diabetes.
    Li Y; Ma WG; Li XC
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Selection of risk and diagnosis in diabetic polyneuropathy. Validation of method of new systems].
    Jurado J; Caula J; Pou i Torelló JM
    Aten Primaria; 2006 Jun; 38(2):116-21. PubMed ID: 16828016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).
    Cabezas-Cerrato J
    Diabetologia; 1998 Nov; 41(11):1263-9. PubMed ID: 9833931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population.
    Hu Y; Liu F; Shen J; Zeng H; Li L; Zhao J; Zhao J; Lu F; Jia W
    Eur J Endocrinol; 2014 Nov; 171(5):641-8. PubMed ID: 25184282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of diabetic peripheral neuropathy among type II diabetic patients in King Fahd University Hospital, Khobar, Kingdom of Saudi Arabia.
    Jatooi NA; Alsulaiman ASA; Alromaih NJ; Abdullah Albahrani B; Alkhattaf IM; Alyami F; Alabdrabalrasol KA
    Hosp Pract (1995); 2021 Apr; 49(2):63-70. PubMed ID: 33216654
    [No Abstract]   [Full Text] [Related]  

  • 47. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus.
    Guo K; Elzinga S; Eid S; Figueroa-Romero C; Hinder LM; Pacut C; Feldman EL; Hur J
    Epigenetics; 2019 Aug; 14(8):766-779. PubMed ID: 31132961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural Nerve Remodeling at 3-T MR Neurography Differs between Painful and Painless Diabetic Polyneuropathy in Type 1 or 2 Diabetes.
    Jende JME; Groener JB; Kender Z; Rother C; Hahn A; Hilgenfeld T; Juerchott A; Preisner F; Heiland S; Kopf S; Nawroth P; Bendszus M; Kurz FT
    Radiology; 2020 Feb; 294(2):405-414. PubMed ID: 31891321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Association between Genomic DNA Methylation and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.
    Zhang HH; Han X; Wang M; Hu Q; Li S; Wang M; Hu J
    J Diabetes Res; 2019; 2019():2494057. PubMed ID: 31781662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
    Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
    Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative proteomic analysis of human peripheral nerves from subjects with type 2 diabetes.
    Ising E; Åhrman E; Thomsen NOB; Eriksson KF; Malmström J; Dahlin LB
    Diabet Med; 2021 Nov; 38(11):e14658. PubMed ID: 34309080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
    Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
    J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes.
    Riandini T; Wee HL; Khoo EYH; Tai BC; Wang W; Koh GCH; Tai ES; Tavintharan S; Chandran K; Hwang SW; Venkataraman K
    Acta Diabetol; 2018 Feb; 55(2):155-164. PubMed ID: 29185052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
    Kim ES; Lee SW; Mo EY; Moon SD; Han JH
    Endocrine; 2015 Nov; 50(2):405-12. PubMed ID: 25846483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouse models of diabetic neuropathy.
    O'Brien PD; Sakowski SA; Feldman EL
    ILAR J; 2014; 54(3):259-72. PubMed ID: 24615439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of photobiomodulation on serum neuron specific enolase (NSE) among patients with diabetic peripheral neuropathy - A pilot study.
    M A; Ummer V S; Maiya AG; Hande M; V S B
    Diabetes Metab Syndr; 2020; 14(5):1061-1063. PubMed ID: 32645648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
    Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
    Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes.
    Nomura T; Ishiguro T; Ohira M; Ikeda Y
    J Diabetes Investig; 2018 Jan; 9(1):186-192. PubMed ID: 28296226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis].
    Zhong H; Xu LL; Bai MX; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1026-1031. PubMed ID: 34916676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Baltzis D; Roustit M; Grammatikopoulou MG; Katsaboukas D; Athanasiou V; Iakovou I; Veves A; Manes C; Trakatelli MC
    Adv Ther; 2016 Oct; 33(10):1840-1847. PubMed ID: 27554090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.